Related Experiment Video
Updated: Apr 5, 2026

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.7K
Making the Case to Study the Volume-Outcome Relationship in Hematologic Cancers
Ronald S Go1, Wayne A Bottner2, Morie A Gertz3
1Division of Hematology, Mayo Clinic, Rochester, MN; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN.
Mayo Clinic Proceedings
|August 24, 2015
Summary
The volume of health services impacts patient outcomes in cancer care. Further research is needed to understand the volume-outcome relationship in hematologic cancer management.
Area of Science:
- Oncology
- Health Services Research
- Medical Education
Background:
- A positive volume-outcome relationship is established for surgical cancer treatment and other complex conditions.
- This relationship remains under-explored in the medical management of cancers, particularly hematologic malignancies.
Purpose of the Study:
- To summarize the current knowledge on the volume-outcome relationship in hematologic cancer care.
- To identify the need for further research in this area.
Main Methods:
- Literature review and synthesis of existing data on volume-outcome relationships in hematologic cancers.
- Analysis of factors influencing the complexity and management of hematologic cancers.
Main Results:
- Hematologic cancers have a relatively low annual volume in the United States.
- Diagnosis complexity is increasing due to evolving classifications and prognostication.
- Novel agents and disease-specific guidelines add to treatment complexity.
Conclusions:
- Further research into the volume-outcome relationship in hematologic cancer management is crucial.
- Understanding this relationship can inform medical practice, quality of care, and subspecialty training.
Related Concept Videos
Bone Marrow Sampling and Transplants
2.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K
Overview of Hematopoiesis
11.6K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
11.6K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Role of Hematopoietic Growth Factors
4.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.4K
Treatment Resistent Cancers
1.5K
1.5K
Hematopoiesis
9.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.9K
